Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMC

Mesenchymal stem cell subpopulations: phenotype, property and therapeutic potential

Mo M., Wang S., Zhou Y., Li H., Wu Y.

Narrative Review on Face & Skin, published in Cell Mol Life Sci (2016) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Cell Mol Life Sci (2016)
Reported sample size
—
Source database
Europe PMC
PMID
27141940
PMCID
PMC11108490
DOI
10.1007/s00018-016-2229-7
Citations
104

Abstract (original English)

Mesenchymal stem cells (MSC) are capable of differentiating into cells of multiple cell lineages and have potent paracrine effects. Due to their easy preparation and low immunogenicity, MSC have emerged as an extremely promising therapeutic agent in regenerative medicine for diverse diseases. However, MSC are heterogeneous with respect to phenotype and function in current isolation and cultivation regimes, which often lead to incomparable experimental results. In addition, there may be specific stem cell subpopulations with definite differentiation capacity toward certain lineages in addition to stem cells with multi-differentiation potential. Recent studies have identified several subsets of MSC which exhibit distinct features and biological activities, and enhanced therapeutic potentials for certain diseases. In this review, we give an overview of these subsets for their phenotypic, biological and functional properties.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Mesenchymal Stem CellsHumansReceptors, Platelet-Derived Growth FactorVascular Cell Adhesion Molecule-1Receptors, CXCR4Receptors, Nerve Growth FactorNerve Tissue ProteinsAntigens, SurfaceRegenerative MedicineCell Differentiation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research